pentobarbital has been researched along with Experimental Leukemia in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson-White, A | 1 |
| Whyatt, PL | 1 |
| Cramer, JW | 1 |
2 other studies available for pentobarbital and Experimental Leukemia
| Article | Year |
|---|---|
Mechanisms of action of anesthetics on inositol phospholipid hydrolysis in vascular endothelial cells and rat basophilic leukemia cells in tissue culture.
Topics: Anesthetics; Angiotensin II; Animals; Aorta, Thoracic; Barbiturates; Basophils; Calcium; Cell Membra | 1991 |
Barbiturate inhibition of growth and of synthesis of deoxyribonucleic acid, ribonucleic acid and protein in cultured mammalian cells.
Topics: Animals; Barbiturates; Cell Line; Clone Cells; DNA, Neoplasm; Leucine; Leukemia, Experimental; Mast- | 1973 |